Low-grade B-cell proliferation progressing to high-grade B-cell lymphoma

American Journal of Dermatopathology

Volumn 31, Issue 6, 2009, Pages 578-581

  Martin, Blanca ^a   Craig, Paul ^a   Grattan, Clive ^a   Mitchell, Tracey ^a   Ferreira, Silvia ^a   Whittaker, Sean ^a   Robson, Alistair ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cutaneous lymphoidhyperplasia; Primary cutaneous marginal zone lymphoma; Progression; Transformation

Indexed keywords

CELL MARKER; COMPLEMENT COMPONENT C3D RECEPTOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN HEAVY CHAIN; PREDNISONE; PROTEIN BCL 2; RITUXIMAB; VINCRISTINE;

AGED; ARM; ARTICLE; B LYMPHOCYTE; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CASE REPORT; CERVICAL LYMPHADENOPATHY; CONSULTATION; CYTOPLASM; DERMIS; DIFFERENTIAL DIAGNOSIS; FACE; FEMALE; GERMINAL CENTER; HUMAN; IMMUNOCYTOCHEMISTRY; LARGE CELL LYMPHOMA; LIGHT CHAIN; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; LYMPHOID HYPERPLASIA; MALIGNANT TRANSFORMATION; MARGINAL ZONE LYMPHOMA; PAPULE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; SKIN BIOPSY; SKIN INFILTRATE; SKIN LYMPHOMA; TRUNK; WEIGHT REDUCTION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS;

EID: 68949163532     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181a412cb     Document Type: Article

References (9)

1. Willemze R. Primary cutaneous B-cell lymphoma: classification and treatment. Curr Opin Oncol. 2006; 18:425-431
2. Hoefnagel JJ, Vermeer MH, Jansen PM, et al. Primary cutaneous marginal zone B cell lymphoma. Clinical and therapeutic features in 50 cases. Arch Dermatol. 2005;141:1139-1145
3. Zinzani PL, Quaglino P, Pimpinelli N, et al. Prognostic factors in primary cutaneous B-cell Lymphoma: the Italian study group for cutaneous lymphomas. J Clin Oncol. 2006;24:1376-1382.
4. Servitje O, Gallardo F, Estrach T, et al. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol. 2002;147:1147-1158
5. Garcia MJ, Martinez-Delgado B, Granizo JJ, et al. IgH, TCR-g and TCR-B gene rearrangement in 80 B and T-cell non-Hodgkin's lymphomas: study of the association between proliferation and the so-called "aberrant" patterns. Diagn Mol Pathol. 2001;10:69-77
6. Hsu MY, Murphy GF. Cutaneous lymphomas and leukemias. In: Elder DE, ed. Lever's Histopathology of the Skin. Philadelphia, PA: Lippincott Williams & Wilkins; 2009:911-968.
7. Cutaneous lymphoproliferative diseases and related disorders. In: McKee PH, Calonje E, Granter SR, eds. Pathology of the Skin With Clinical Correlation. Philadelphia, PA: Elsevier Mosby; 2005:1357-1495.
8. Culow BC, Cualig H, Steele P, et al. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma. J Cutan Med Surg. 2002; 6:519-528.
9. Kazakov D, Kutzner H, Palmedo G, et al. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement. Am J Dermatopathol. 2006;28:399-409.